Sort
39,280 grants matching “leukemia”
A new molecular therapy against ocular herpes
$399,750Deepak Shukla · University Of Illinois At Chicago · R01 · FY2017 · EY
Biochemistry of Leukemia Virus Core Binding Factor
$399,750Nancy Asmussen Speck · Dartmouth College · R01 · FY2008 · HL
The role of EVI1-induced hypermethylation in leukemogenesis.
$399,750Zhijian Qian · University Of Illinois At Chicago · R01 · FY2017 · HL
Targeting DYRK2 to eradicate leukemia stem cells in chronic myeloid leukemia.
$399,746H. Daniel Lacorazza · Baylor College Of Medicine · R01 · FY2025 · CA
Preclinical development of a tandem CART / HSC transplantation platform for hematologic malignancies
$399,739Jeremy A Elser · Ship Of Theseus, Llc · R41 · FY2025 · CA
The role of EVI1-induced hypermethylation in leukemogenesis.
$399,708Zhijian Qian · University Of Illinois At Chicago · R01 · FY2016 · HL
Structure and Functions of Steroid Hormone Receptors
$399,681H Eric Xu · Van Andel Research Institute · R01 · FY2007 · DK
Simultaneous Targeting of Tumor and Stroma Cells to Enhance Solid Tumor CAR-T Cell Therapy
$399,658Nicole J. Shirkey-Son · Luminary Therapeutics, Inc. · R43 · FY2021 · CA
Project 1
$399,645Charles E Chalfant · University Of Virginia · P01 · FY2025 · CA
Oncogenic tyrosine kinases inhibitors abrogate DNA repair and sensitive leukemias to PARP inhibitors
$399,571Tomasz Skorski · Temple Univ Of The Commonwealth · R01 · FY2023 · CA
Oncogenic tyrosine kinases inhibitors abrogate DNA repair and sensitive leukemias to PARP inhibitors
$399,569Tomasz Skorski · Temple Univ Of The Commonwealth · R01 · FY2022 · CA
A new molecular therapy against ocular herpes
$399,521Deepak Shukla · University Of Illinois At Chicago · R01 · FY2015 · EY
Abnormal Stem Cell Trafficking in IM
$399,509Ronald Hoffman · Icahn School Of Medicine At Mount Sinai · P01 · FY2011 · CA
Role of APOBEC3 in in vivo Restriction of Retrovirus Infection
$399,500Susan R Ross · University Of Illinois At Chicago · R01 · FY2016 · AI
Molecular Basis of Drosophila Homeotic Gene Regulation
$399,483Case Western Reserve University · R01 · FY2005 · GM
SOUTHWEST ONCOLOGY GROUP
$399,443Swedish Medical Center, First Hill · U10 · FY2002 · CA
Using Stat3 Signaling Profiles to Understand Chemotherapy Resistance in AML
$399,401Michele S. Redell · Baylor College Of Medicine · R01 · FY2015 · CA
ROLE OF SHORT TELOMERES IN GENOMIC INSTABLITIY AND TUMOR INITIATION
$399,392Carol W Greider · Johns Hopkins University · P01 · FY2008 · CA
Notch-induced protein degradation in lymphopoiesis
$399,391Xiao-Hong Sun · Oklahoma Medical Research Foundation · R01 · FY2011 · AI
Notch-induced protein degradation in lymphopoiesis
$399,391Xiao-Hong Sun · Oklahoma Medical Research Foundation · R01 · FY2012 · AI
LEUKEMOGENESIS BY ABL AND OTHER ONCOGENES
$399,348California Institute Of Technology · R01 · FY2004 · CA
Microfluidic Techniques for the Molecular and Functional Analysis of Gene Express
$399,301Stephen R Quake · Stanford University · P01 · FY2010 · CA
Activation and Regulation of the Understudied Kinome Using MIB/MS Technology
$399,282Gary L. Johnson · Univ Of North Carolina Chapel Hill · U01 · FY2014 · MH
Mitochondrial Maintenance Mechanisms of Stem Cells and Aging
$399,247Hans-Willem E Snoeck · Columbia University Health Sciences · R01 · FY2017 · AG
Formaldehyde Genotoxicity
$399,209Anatoly Zhitkovich · Brown University · R01 · FY2016 · ES